MULTIPLE CLINICAL APPLICATIONS

Measuring the neutralizing antibodies potency are expected to build a defense against SARS-CoV-2 spreading, complementing vaccines and nonpharmaceutical interventions.

For vaccine efficacy monitoring

Understanding the human body’s immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.

For treatment options guiding

Potent nAbs that were more effective at neutralizing the virus have better clinical outcomes. Early administration of nAbs is vital to identify patient of severity risk as an aid to treatment.

• Cost-effective, reproducible and time-saving

• Only 10 mins for results.Suitable for large scale testing to

• evaluate herd immunity in community

• High sensitivity and specificity

• Up to 100% positive agreement with gold standard VNT

Comparison